Zhejiang Tianyu Pharmaceutical Co., Ltd. (SHE:300702)

Market Cap	8.70B +50.4%
Revenue (ttm)	2.99B +15.1%
Net Income	191.75M +339.0%
EPS	0.55 +343.3%
Shares Out	343.93M
PE Ratio	45.75
Forward PE	32.66
Dividend	0.05 (0.20%)
Ex-Dividend Date	n/a

Volume	3,646,300
Average Volume	4,452,560
Open	25.73
Previous Close	25.31
Day's Range	24.66 - 25.73
52-Week Range	16.40 - 31.20
Beta	0.62
RSI	45.15
Earnings Date	Apr 24, 2026

About SHE:300702

Zhejiang Tianyu Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical intermediates and APIs in China and internationally. The company offers pharmaceutical intermediates and APIs of anti-hypertensive, anti-asthmatic, hypoglycemic, hypolipidemic, and anticoagulant series. It provides fine chemicals and CDMO services. Zhejiang Tianyu Pharmaceutical Co., Ltd. was founded in 1993 and is based in Taizhou, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1993
• Employees: 4,532
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300702

Financial Performance

In 2024, SHE:300702's revenue was 2.63 billion, an increase of 4.10% compared to the previous year's 2.53 billion. Earnings were 55.94 million, an increase of 104.45%.